These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25388820)

  • 1. Pancreatic cancer genomics: where can the science take us?
    Graham JS; Jamieson NB; Rulach R; Grimmond SM; Chang DK; Biankin AV
    Clin Genet; 2015 Sep; 88(3):213-9. PubMed ID: 25388820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer subtypes: a roadmap for precision medicine.
    Torres C; Grippo PJ
    Ann Med; 2018 Jun; 50(4):277-287. PubMed ID: 29537309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine in pancreatic cancer: treating every patient as an exception.
    Herbst B; Zheng L
    Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):805-810. PubMed ID: 31511204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective.
    Perales-Patón J; Piñeiro-Yañez E; Tejero H; López-Casas PP; Hidalgo M; Gómez-López G; Al-Shahrour F
    Public Health Genomics; 2017; 20(2):81-91. PubMed ID: 28858862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer.
    Malgerud L; Lindberg J; Wirta V; Gustafsson-Liljefors M; Karimi M; Moro CF; Stecker K; Picker A; Huelsewig C; Stein M; Bohnert R; Del Chiaro M; Haas SL; Heuchel RL; Permert J; Maeurer MJ; Brock S; Verbeke CS; Engstrand L; Jackson DB; Grönberg H; Löhr JM
    Mol Oncol; 2017 Oct; 11(10):1413-1429. PubMed ID: 28675654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoid models for translational pancreatic cancer research.
    Tiriac H; Plenker D; Baker LA; Tuveson DA
    Curr Opin Genet Dev; 2019 Feb; 54():7-11. PubMed ID: 30844513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Medicine and Pancreatic Cancer.
    George B
    Surg Oncol Clin N Am; 2021 Oct; 30(4):693-708. PubMed ID: 34511190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
    Connor AA; Gallinger S
    Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):683-694. PubMed ID: 28460572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants.
    Giri B; Sethi V; Dudeja V; Banerjee S; Livingstone A; Saluja A
    Curr Opin Gastroenterol; 2017 Sep; 33(5):404-410. PubMed ID: 28682795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics of pancreatic ductal adenocarcinoma.
    Pilarsky C; Grutzmann R
    Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):381-5. PubMed ID: 25100122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
    JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular landscape of pancreatic cancer: challenges and clinical implications.
    Kyrochristos ID; Ziogas DE; Glantzounis GK; Roukos DH
    Future Oncol; 2017 Dec; 13(30):2741-2744. PubMed ID: 29182377
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial.
    Aung KL; Fischer SE; Denroche RE; Jang GH; Dodd A; Creighton S; Southwood B; Liang SB; Chadwick D; Zhang A; O'Kane GM; Albaba H; Moura S; Grant RC; Miller JK; Mbabaali F; Pasternack D; Lungu IM; Bartlett JMS; Ghai S; Lemire M; Holter S; Connor AA; Moffitt RA; Yeh JJ; Timms L; Krzyzanowski PM; Dhani N; Hedley D; Notta F; Wilson JM; Moore MJ; Gallinger S; Knox JJ
    Clin Cancer Res; 2018 Mar; 24(6):1344-1354. PubMed ID: 29288237
    [No Abstract]   [Full Text] [Related]  

  • 14. New challenges in perioperative management of pancreatic cancer.
    Puleo F; Maréchal R; Demetter P; Bali MA; Calomme A; Closset J; Bachet JB; Deviere J; Van Laethem JL
    World J Gastroenterol; 2015 Feb; 21(8):2281-93. PubMed ID: 25741134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.
    Ruess DA; Görgülü K; Wörmann SM; Algül H
    Drugs Aging; 2017 May; 34(5):331-357. PubMed ID: 28349415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the management of pancreatic cancer: surgery is not enough.
    Ansari D; Gustafsson A; Andersson R
    World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular landscape of pancreatic ductal adenocarcinoma.
    Sivapalan L; Kocher HM; Ross-Adams H; Chelala C
    Pancreatology; 2022 Nov; 22(7):925-936. PubMed ID: 35927150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma.
    Bai RL; Wang NY; Zhao LL; Zhang YF; Cui JW
    Hepatobiliary Pancreat Dis Int; 2022 Feb; 21(1):10-24. PubMed ID: 34538570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
    Chandana S; Babiker HM; Mahadevan D
    Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.
    Birnbaum DJ; Bertucci F; Finetti P; Birnbaum D; Mamessier E
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):248-255. PubMed ID: 29499330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.